People | Locations | Statistics |
---|---|---|
Naji, M. |
| |
Motta, Antonella |
| |
Aletan, Dirar |
| |
Mohamed, Tarek |
| |
Ertürk, Emre |
| |
Taccardi, Nicola |
| |
Kononenko, Denys |
| |
Petrov, R. H. | Madrid |
|
Alshaaer, Mazen | Brussels |
|
Bih, L. |
| |
Casati, R. |
| |
Muller, Hermance |
| |
Kočí, Jan | Prague |
|
Šuljagić, Marija |
| |
Kalteremidou, Kalliopi-Artemi | Brussels |
|
Azam, Siraj |
| |
Ospanova, Alyiya |
| |
Blanpain, Bart |
| |
Ali, M. A. |
| |
Popa, V. |
| |
Rančić, M. |
| |
Ollier, Nadège |
| |
Azevedo, Nuno Monteiro |
| |
Landes, Michael |
| |
Rignanese, Gian-Marco |
|
Amaral, Mh
in Cooperation with on an Cooperation-Score of 37%
Topics
Publications (7/7 displayed)
- 2016Therapeutic Strategies for Alzheimer's and Parkinson's Diseases by Means of Drug Delivery Systemscitations
- 2016New thermoresponsive eyedrop formulation containing ibuprofen loaded-nanostructured lipid carriers (NLC): Development, characterization and biocompatibility studies
- 2016New thermoresponsive eyedrop formulation containing ibuprofen loaded-nanostructured lipid carriers (NLC): Development, characterization and biocompatibility studies
- 2016New Thermoresponsive Eyedrop Formulation Containing Ibuprofen Loaded-Nanostructured Lipid Carriers (NLC): Development, Characterization and Biocompatibility Studiescitations
- 2015Nanotechnological carriers for cancer chemotherapy: The state of the artcitations
- 2014In situ gelling systems: a strategy to improve the bioavailability of ophthalmic pharmaceutical formulationscitations
- 2009Rheological properties of vaginal hydrophilic polymer gelscitations
Places of action
Organizations | Location | People |
---|
document
Nanotechnological carriers for cancer chemotherapy: The state of the art
Abstract
Cancer is a term used for a heterogeneous group of malignant diseases in which abnormal cells divide without control and are able to invade other tissues, resulting in metastasis. According to the last data of World Health Organization the incidence and mortality rates of cancer are high and tend to increase. Chemotherapy is usually used in cancer treatments, but due to the lack of specificity of drugs, is associated to various and damaging side effects that have a severe impact on patients quality of life. Nanotechnology is actually an important area of interest in science and technology, which has been extensively explored during the last decade, particularly in the development of carriers for cytotoxic drugs. These carriers include vesicular and particulate systems such as liposomes, niosomes, transfersomes, ethosomes, micelles, dendrimers, and polymeric, protein and lipid nanoparticles. Polymer-drug conjugates and antibody-drug conjugates have also been studied. The present review is an attempt to contemplate the studied nanocarriers in the field of anticancer drugs delivery, their advantages and disadvantages and future perspectives.